Protein kinase inhibitors are a well-established class of clinically useful drugs, particularly for the treatment of cancer. Measurement and prediction of kinase inhibitor selectivity will be important for the development of new multi-targeted kinase inhibitors.
SPR is label-free and capable of measuring real-time quantitative binding affinities and kinetics for kinases interacting with ligand molecules using relatively small quantities of materials and has potential to be medium-throughput.
It can be used with a wide range of kinase systems including GPCRs, which are the major molecular targets for current validated drugs and for foreseeable drug discovery.
Thank you for your interest in our Enzyme Kinetic Assays With SPR services. Please complete the form below and we will contact you shortly.
Fields indicated by an * are required.